- Accueil >
- Publications >
- Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
Auteurs
S. Gourgou-Bourgade, D. Cameron, P. Poortmans, B. Asselain, D. Azria, F. Cardoso, R. A'Hern, J. Bliss, J. Bogaerts, H. Bonnefoi, E. Brain, M.J. Cardoso, B. Chibaudel, R. Coleman, T. Cufer, L. Dal Lago, F. Dalenc, E. De Azambuja, M. Debled, S. Delaloge, T. Filleron, J. Gligorov, M. Gutowski, W. Jacot, C. Kirkove, G. MacGrogan, S. Michiels, I. Negreiros, B.V. Offersen, F. Penault Llorca, G. Pruneri, H. Roche, N.S. Russell, F. Schmitt, V. Servent, B. Thürlimann, M. Untch, J.A. van der Hage, G. van Tienhoven, H. Wildiers, J. Yarnold, F. Bonnetain, S. Mathoulin-Pélissier, C. Bellera, T.S. Dabakuyo-Yonli